Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20460520rdf:typepubmed:Citationlld:pubmed
pubmed-article:20460520lifeskim:mentionsumls-concept:C1622968lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C0023693lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C0042196lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C1420817lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C1718423lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:20460520lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:20460520pubmed:issue10lld:pubmed
pubmed-article:20460520pubmed:dateCreated2010-5-14lld:pubmed
pubmed-article:20460520pubmed:abstractTextLIGHT, a ligand for the lymphotoxin-beta receptor, establishes lymphoid-like tissues inside tumor sites and recruits naïve T cells into the tumor. However, whether these infiltrating T cells are specific for tumor antigens is not known. We hypothesized that therapy with LIGHT can expand functional tumor-specific CD8(+) T cells that can be boosted using HPV16E6E7-Venezuelan equine encephalitis virus replicon particles (HPV16-VRP) and that this combined therapy can eradicate human papillomavirus 16 (HPV16)-induced tumors. Our data show that forced expression of LIGHT in tumors results in an increase in expression of IFNgamma and chemoattractant cytokines such as interleukin-1a, MIG, and macrophage inflammatory protein-2 within the tumor and that this tumor microenvironment correlates with an increase in frequency of tumor-infiltrating CD8(+) T cells. Forced expression of LIGHT also results in the expansion of functional T cells that recognize multiple tumor antigens, including HPV16 E7, and these T cells prevent the outgrowth of tumors on secondary challenge. Subsequent boosting of E7-specific T cells by vaccination with HPV16-VRP significantly increases their frequency in both the periphery and the tumor and leads to the eradication of large well-established tumors, for which either treatment alone is not successful. These data establish the safety of Ad-LIGHT as a therapeutic intervention in preclinical studies and suggest that patients with HPV16(+) tumors may benefit from combined immunotherapy with LIGHT and antigen-specific vaccination.lld:pubmed
pubmed-article:20460520pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:languageenglld:pubmed
pubmed-article:20460520pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:citationSubsetIMlld:pubmed
pubmed-article:20460520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20460520pubmed:statusMEDLINElld:pubmed
pubmed-article:20460520pubmed:monthMaylld:pubmed
pubmed-article:20460520pubmed:issn1538-7445lld:pubmed
pubmed-article:20460520pubmed:authorpubmed-author:FuYang-XinYXlld:pubmed
pubmed-article:20460520pubmed:authorpubmed-author:KastW...lld:pubmed
pubmed-article:20460520pubmed:authorpubmed-author:Da...lld:pubmed
pubmed-article:20460520pubmed:authorpubmed-author:BogaertLiesLlld:pubmed
pubmed-article:20460520pubmed:authorpubmed-author:KanodiaShreya...lld:pubmed
pubmed-article:20460520pubmed:authorpubmed-author:KaramanukyanT...lld:pubmed
pubmed-article:20460520pubmed:copyrightInfo(c)2010 AACR.lld:pubmed
pubmed-article:20460520pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20460520pubmed:day15lld:pubmed
pubmed-article:20460520pubmed:volume70lld:pubmed
pubmed-article:20460520pubmed:ownerNLMlld:pubmed
pubmed-article:20460520pubmed:authorsCompleteYlld:pubmed
pubmed-article:20460520pubmed:pagination3955-64lld:pubmed
pubmed-article:20460520pubmed:dateRevised2011-7-28lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:meshHeadingpubmed-meshheading:20460520...lld:pubmed
pubmed-article:20460520pubmed:year2010lld:pubmed
pubmed-article:20460520pubmed:articleTitleExpression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regression.lld:pubmed
pubmed-article:20460520pubmed:affiliationDepartment of Molecular Microbiology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California 90033, USA.lld:pubmed
pubmed-article:20460520pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20460520pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
More...